Bartlett & CO. Wealth Management LLC trimmed its holdings in shares of UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 2.6% in the 1st quarter, according to its most recent disclosure with the SEC. The fund owned 171,259 shares of the healthcare conglomerate's stock after selling 4,654 shares during the period. UnitedHealth Group makes up approximately 1.3% of Bartlett & CO. Wealth Management LLC's holdings, making the stock its 22nd largest position. Bartlett & CO. Wealth Management LLC's holdings in UnitedHealth Group were worth $89,697,000 as of its most recent SEC filing.
Several other hedge funds and other institutional investors also recently made changes to their positions in UNH. NewSquare Capital LLC purchased a new position in UnitedHealth Group in the 4th quarter worth approximately $25,000. Marshall & Sterling Wealth Advisors Inc. bought a new position in shares of UnitedHealth Group during the fourth quarter valued at $26,000. Hurley Capital LLC bought a new stake in UnitedHealth Group in the 4th quarter worth about $28,000. Aster Capital Management DIFC Ltd bought a new position in UnitedHealth Group during the 4th quarter valued at about $30,000. Finally, Promus Capital LLC bought a new stake in shares of UnitedHealth Group in the fourth quarter worth approximately $32,000. Hedge funds and other institutional investors own 87.86% of the company's stock.
Insiders Place Their Bets
In related news, CEO Stephen J. Hemsley purchased 86,700 shares of the company's stock in a transaction that occurred on Friday, May 16th. The stock was bought at an average price of $288.57 per share, for a total transaction of $25,019,019.00. Following the completion of the transaction, the chief executive officer now owns 679,493 shares in the company, valued at approximately $196,081,295.01. The trade was a 14.63% increase in their position. The purchase was disclosed in a filing with the SEC, which is available at the SEC website. Also, CEO Patrick Hugh Conway sold 589 shares of the company's stock in a transaction that occurred on Tuesday, June 10th. The shares were sold at an average price of $305.00, for a total value of $179,645.00. Following the sale, the chief executive officer now owns 10,398 shares in the company, valued at approximately $3,171,390. This trade represents a 5.36% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders acquired 109,408 shares of company stock valued at $31,607,768 in the last three months. Corporate insiders own 0.28% of the company's stock.
UnitedHealth Group Price Performance
Shares of UnitedHealth Group stock traded up $6.23 on Friday, hitting $308.85. 13,584,804 shares of the company traded hands, compared to its average volume of 7,448,059. The stock has a market capitalization of $280.17 billion, a P/E ratio of 12.93, a price-to-earnings-growth ratio of 1.43 and a beta of 0.44. The business has a 50-day simple moving average of $339.15 and a 200 day simple moving average of $456.28. UnitedHealth Group Incorporated has a 52 week low of $248.88 and a 52 week high of $630.73. The company has a debt-to-equity ratio of 0.71, a quick ratio of 0.85 and a current ratio of 0.85.
UnitedHealth Group (NYSE:UNH - Get Free Report) last issued its earnings results on Thursday, April 17th. The healthcare conglomerate reported $7.20 earnings per share (EPS) for the quarter, missing the consensus estimate of $7.29 by ($0.09). UnitedHealth Group had a return on equity of 26.29% and a net margin of 5.39%. The firm had revenue of $109.58 billion during the quarter, compared to the consensus estimate of $111.56 billion. During the same period last year, the firm posted $6.91 earnings per share. Research analysts expect that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current fiscal year.
UnitedHealth Group Increases Dividend
The firm also recently declared a quarterly dividend, which was paid on Tuesday, June 24th. Investors of record on Monday, June 16th were paid a dividend of $2.21 per share. This is an increase from UnitedHealth Group's previous quarterly dividend of $2.10. The ex-dividend date of this dividend was Monday, June 16th. This represents a $8.84 dividend on an annualized basis and a yield of 2.86%. UnitedHealth Group's dividend payout ratio is presently 37.02%.
Analyst Upgrades and Downgrades
A number of equities research analysts have commented on the stock. Deutsche Bank Aktiengesellschaft cut their target price on shares of UnitedHealth Group from $521.00 to $362.00 and set a "buy" rating for the company in a research report on Wednesday, May 14th. Hsbc Global Res downgraded UnitedHealth Group from a "hold" rating to a "moderate sell" rating in a report on Wednesday, May 21st. TD Cowen lowered shares of UnitedHealth Group from a "buy" rating to a "hold" rating and set a $308.00 price target for the company. in a research report on Monday, May 19th. Wall Street Zen downgraded shares of UnitedHealth Group from a "buy" rating to a "hold" rating in a report on Saturday, May 24th. Finally, Oppenheimer decreased their price target on shares of UnitedHealth Group from $600.00 to $400.00 and set an "outperform" rating on the stock in a research report on Wednesday, May 14th. One investment analyst has rated the stock with a sell rating, nine have assigned a hold rating and sixteen have assigned a buy rating to the company. According to MarketBeat, the company has an average rating of "Moderate Buy" and a consensus target price of $415.57.
View Our Latest Report on UNH
UnitedHealth Group Company Profile
(
Free Report)
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.
Read More

Before you consider UnitedHealth Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and UnitedHealth Group wasn't on the list.
While UnitedHealth Group currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Need to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.